TY - JOUR
T1 - A core outcome set for aphasia treatment research
T2 - The ROMA consensus statement
AU - Wallace, Sarah J.
AU - Worrall, Linda
AU - Rose, Tanya
AU - Le Dorze, Guylaine
AU - Breitenstein, Caterina
AU - Hilari, Katerina
AU - Babbitt, Edna
AU - Bose, Arpita
AU - Brady, Marian
AU - Cherney, Leora R.
AU - Copland, David
AU - Cruice, Madeline
AU - Enderby, Pam
AU - Hersh, Deborah
AU - Howe, Tami
AU - Kelly, Helen
AU - Kiran, Swathi
AU - Laska, Ann Charlotte
AU - Marshall, Jane
AU - Nicholas, Marjorie
AU - Patterson, Janet
AU - Pearl, Gill
AU - Rochon, Elizabeth
AU - Rose, Miranda
AU - Sage, Karen
AU - Small, Steven
AU - Webster, Janet
N1 - Publisher Copyright:
© 2018 World Stroke Organization.
PY - 2019/2/1
Y1 - 2019/2/1
N2 - Background: A core outcome set (COS; an agreed, minimum set of outcomes) was needed to address the heterogeneous measurement of outcomes in aphasia treatment research and to facilitate the production of transparent, meaningful, and efficient outcome data. Objective: The Research Outcome Measurement in Aphasia (ROMA) consensus statement provides evidence-based recommendations for the measurement of outcomes for adults with post-stroke aphasia within phases I–IV aphasia treatment studies. Methods: This statement was informed by a four-year program of research, which comprised investigation of stakeholder-important outcomes using consensus processes, a scoping review of aphasia outcome measurement instruments, and an international consensus meeting. This paper provides an overview of this process and presents the results and recommendations arising from the international consensus meeting. Results: Five essential outcome constructs were identified: Language, communication, patient-reported satisfaction with treatment and impact of treatment, emotional wellbeing, and quality of life. Consensus was reached for the following measurement instruments: Language: The Western Aphasia Battery Revised (WAB-R) (74% consensus); emotional wellbeing: General Health Questionnaire (GHQ)-12 (83% consensus); quality of life: Stroke and Aphasia Quality of Life Scale (SAQOL-39) (96% consensus). Consensus was unable to be reached for measures of communication (where multiple measures exist) or patient-reported satisfaction with treatment or impact of treatment (where no measures exist). Discussion: Harmonization of the ROMA COS with other core outcome initiatives in stroke rehabilitation is discussed. Ongoing research and consensus processes are outlined. Conclusion: The WAB-R, GHQ-12, and SAQOL-39 are recommended to be routinely included within phases I–IV aphasia treatment studies. This consensus statement has been endorsed by the Collaboration of Aphasia Trialists, the British Aphasiology Society, the German Society for Aphasia Research and Therapy, and the Royal College of Speech Language Therapists.
AB - Background: A core outcome set (COS; an agreed, minimum set of outcomes) was needed to address the heterogeneous measurement of outcomes in aphasia treatment research and to facilitate the production of transparent, meaningful, and efficient outcome data. Objective: The Research Outcome Measurement in Aphasia (ROMA) consensus statement provides evidence-based recommendations for the measurement of outcomes for adults with post-stroke aphasia within phases I–IV aphasia treatment studies. Methods: This statement was informed by a four-year program of research, which comprised investigation of stakeholder-important outcomes using consensus processes, a scoping review of aphasia outcome measurement instruments, and an international consensus meeting. This paper provides an overview of this process and presents the results and recommendations arising from the international consensus meeting. Results: Five essential outcome constructs were identified: Language, communication, patient-reported satisfaction with treatment and impact of treatment, emotional wellbeing, and quality of life. Consensus was reached for the following measurement instruments: Language: The Western Aphasia Battery Revised (WAB-R) (74% consensus); emotional wellbeing: General Health Questionnaire (GHQ)-12 (83% consensus); quality of life: Stroke and Aphasia Quality of Life Scale (SAQOL-39) (96% consensus). Consensus was unable to be reached for measures of communication (where multiple measures exist) or patient-reported satisfaction with treatment or impact of treatment (where no measures exist). Discussion: Harmonization of the ROMA COS with other core outcome initiatives in stroke rehabilitation is discussed. Ongoing research and consensus processes are outlined. Conclusion: The WAB-R, GHQ-12, and SAQOL-39 are recommended to be routinely included within phases I–IV aphasia treatment studies. This consensus statement has been endorsed by the Collaboration of Aphasia Trialists, the British Aphasiology Society, the German Society for Aphasia Research and Therapy, and the Royal College of Speech Language Therapists.
KW - Aphasia
KW - consensus
KW - core outcome set
KW - methodology
KW - recommendations
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=85059623959&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059623959&partnerID=8YFLogxK
U2 - 10.1177/1747493018806200
DO - 10.1177/1747493018806200
M3 - Article
C2 - 30303810
AN - SCOPUS:85059623959
SN - 1747-4930
VL - 14
SP - 180
EP - 185
JO - International Journal of Stroke
JF - International Journal of Stroke
IS - 2
ER -